| Lastest Insider Transactions Of Intellia Therapeutics, Inc. ( NTLA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2023-03-01 | Sell | 1,088 | 43.88 | 47,741 | 2023-03-03 17:10:35 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-04 | Sell | 4,838 | 37.82 | 182,982 | 2023-01-06 17:39:56 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2023-01-04 | Sell | 6,673 | 37.21 | 248,302 | 2023-01-06 17:32:49 |
| NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | 2023-01-04 | Sell | 1,812 | 37.21 | 67,425 | 2023-01-06 17:29:43 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2023-01-04 | Sell | 2,574 | 37.21 | 95,779 | 2023-01-06 17:26:38 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2023-01-04 | Sell | 2,427 | 37.21 | 90,309 | 2023-01-06 17:23:40 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2022-07-01 | Sell | 2,028 | 37.65 | 76,357 | 2023-01-06 17:21:01 |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2023-01-04 | Sell | 1,138 | 37.21 | 42,345 | 2023-01-06 17:19:11 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-01 | Option Exercise | 3,500 | 0.00 | 0 | 2023-01-04 20:38:29 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2023-01-01 | Option Exercise | 7,848 | 0.00 | 0 | 2023-01-04 20:36:01 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2023-01-01 | Option Exercise | 3,187 | 0.00 | 0 | 2023-01-04 20:33:03 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2023-01-01 | Option Exercise | 3,062 | 0.00 | 0 | 2023-01-04 20:29:37 |
